What does Clal Biotechnology Industries Ltd. do?

Clal Biotechnology Industries Ltd. (CBI.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is CBI.TA's market cap?

Clal Biotechnology Industries Ltd. (CBI.TA) has a market capitalization of approximately $3.78 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does CBI.TA pay a dividend?

Yes — Clal Biotechnology Industries Ltd. (CBI.TA) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is CBI.TA profitable?

Clal Biotechnology Industries Ltd. (CBI.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

CBI.TA

Clal Biotechnology Industries Ltd.

TLV·Biotechnology · Healthcare

ILA 24.10ILA 0.60+2.55%

Market capILA 3.78B·Aug 26 1:46 PM UTC

Price Chart

ILA 24.10+ILA 0.60 (+2.55%)today

−84.21%CAGR −30.87%

Select date range

FromTo

Jun 4, 2007Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)ILA 0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendILA 22.37

Ex-Dividend DateMar 29

Payment DateApr 6

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateMay 6

Reported vs Estimate−ILA 0.13

Earnings Surprise—

FinancialsFinancials Tab

Revenue₪0.00

Net Income−₪13.32M

Net Margin—

Operating Cash Flow−₪3.95M

Capital Expenditures₪0.00

Free Cash Flow−₪3.95M

Return on Equity−66.0%

Return on Invested Capital−2.4%

Net Debt₪16.07M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for CBI.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how CBI.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CBI.TA and 80,000+ other tickers.

About Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd. (CBI) operates as a venture capital and private equity firm, primarily funding innovative companies within the life sciences, medical device, biopharmaceutical, and broader biotechnology sectors. The firm is adept at investing across a comprehensive spectrum of development stages, ranging from initial incubation, seed, and startup phases, through early, emerging, mid, and late-stage ventures, including pre-clinical development, PIPEs, and growth capital financing. CBI strategically targets companies based in the United States and Israel, typically deploying…

CEO: Avraham Matityahu Fischer
Sector: Healthcare
Industry: Biotechnology
Exchange: TLV
Employees: 121
Website: www.cbi.co.il

Peers

Can-Fite BioPharma Ltd.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About CBI.TA

What does Clal Biotechnology Industries Ltd. do?: Clal Biotechnology Industries Ltd. (CBI.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is CBI.TA's market cap?: Clal Biotechnology Industries Ltd. (CBI.TA) has a market capitalization of approximately $3.78 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does CBI.TA pay a dividend?: Yes — Clal Biotechnology Industries Ltd. (CBI.TA) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is CBI.TA profitable?: Clal Biotechnology Industries Ltd. (CBI.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.